MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1.
作者： Guangyong Chen , Zhuo Chen , Hang Zhao
DOI: 10.1111/JCMM.15192
关键词:
摘要: … The bioinformatics analytical tool TargetScan was employed to comprehend the activity of … Interestingly, we found that the glioma cell resistance to TMZ treatment is enhanced by miR-…
sci-hub.se 参考文章(44)
Zhaoming Li, Tian Tian, Feng Lv, Yu Chang, Xinhua Wang, Lei Zhang, Xin Li, Ling Li, Wang Ma, Jingjing Wu, Mingzhi Zhang, Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0059203
H Ono, I Imoto, K Kozaki, H Tsuda, T Matsui, Y Kurasawa, T Muramatsu, K Sugihara, J Inazawa, SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation Oncogene. ,vol. 31, pp. 4923- 4934 ,(2012) , 10.1038/ONC.2011.646
Joshua C. Anderson, Christine W. Duarte, Karim Welaya, Timothy D. Rohrbach, Markus Bredel, Eddy S. Yang, Nirmal V. Choradia, Jaideep V. Thottassery, George Yancey Gillespie, James A. Bonner, Christopher D. Willey, Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines Radiotherapy and Oncology. ,vol. 111, pp. 468- 474 ,(2014) , 10.1016/J.RADONC.2014.04.010
M. Ahmed, J. Xu, P.-X. Xu, EYA1 and SIX1 drive the neuronal developmental program in cooperation with the SWI/SNF chromatin-remodeling complex and SOX2 in the mammalian inner ear Development. ,vol. 139, pp. 1965- 1977 ,(2012) , 10.1242/DEV.071670
Christine Laclef, Ghislaine Hamard, Josiane Demignon, Evelyne Souil, Christophe Houbron, Pascal Maire, Altered myogenesis in Six1-deficient mice Development. ,vol. 130, pp. 2239- 2252 ,(2003) , 10.1242/DEV.00440
Melanie A Blevins, Christina G Towers, Aaron N Patrick, Rui Zhao, Heide L Ford, The SIX1-EYA transcriptional complex as a therapeutic target in cancer Expert Opinion on Therapeutic Targets. ,vol. 19, pp. 213- 225 ,(2015) , 10.1517/14728222.2014.978860
Tor-Christian Aase Johannessen, Rolf Bjerkvig, Molecular mechanisms of temozolomide resistance in glioblastoma multiforme Expert Review of Anticancer Therapy. ,vol. 12, pp. 635- 642 ,(2012) , 10.1586/ERA.12.37
Gulcin Tezcan, Berrin Tunca, Ahmet Bekar, Matthias Preusser, Anna Sophie Berghoff, Unal Egeli, Gulsah Cecener, Gerda Ricken, Ferah Budak, Mevlut Ozgur Taskapılıoglu, Hasan Kocaeli, Sahsine Tolunay, None, microRNA Expression Pattern Modulates Temozolomide Response in GBM Tumors with Cancer Stem Cells Cellular and Molecular Neurobiology. ,vol. 34, pp. 679- 692 ,(2014) , 10.1007/S10571-014-0050-0
Sam Mattiske, Rachel J. Suetani, Paul M. Neilsen, David F. Callen, The Oncogenic Role of miR-155 in Breast Cancer Cancer Epidemiology Biomarkers & Prevention. ,vol. 21, pp. 1236- 1243 ,(2012) , 10.1158/1055-9965.EPI-12-0173
Heidi G. Møller, Andreas P. Rasmussen, Hjalte H. Andersen, Kasper B. Johnsen, Michael Henriksen, Meg Duroux, A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion Molecular Neurobiology. ,vol. 47, pp. 131- 144 ,(2013) , 10.1007/S12035-012-8349-7